BRIEF-Cellebrite Advances Plans to Transform Strategic Relationship with U.S. Federal Government-March 2024-www.financetom.com

BRIEF-Cellebrite Advances Plans to Transform Strategic Relationship with U.S. Federal Government

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

BRIEF-Cellebrite Advances Plans to Transform Strategic Relationship with U.S. Federal Government

Jul 17, 2024 5:01 AM

July 17 (Reuters) - Cellebrite DI Ltd ( CLBT ):

* CELLEBRITE ADVANCES PLANS TO TRANSFORM AND ELEVATE ITS

STRATEGIC

RELATIONSHIP WITH THE U.S. FEDERAL GOVERNMENT

* CELLEBRITE DI LTD ( CLBT ) - ACQUIRES CYBER TECHNOLOGY SERVICES

* CELLEBRITE - TERMS OF TRANSACTION WERE NOT DISCLOSED

Source text for Eikon:

Further company coverage:

Previous page： Pool Insider Sold Shares Worth $9,581,250, According to a Recent SEC Filing Next page： Halozyme Therapeutics Insider Sold Shares Worth $1,260,681, According to a Recent SEC Filing

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Pool Insider Sold Shares Worth $9,581,250, According to a Recent SEC Filing

Feb 28, 2025

03:48 AM EST, 02/28/2025 (MT Newswires) -- De La Mesa Manuel J Perez, Director, on February 25, 2025, sold 27,500 shares in Pool (POOL) for $9,581,250. Following the Form 4 filing with the SEC, Perez has control over a total of 916,679 common shares of the company, with 62,577 shares held directly and 854,102 controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/945841/000094584125000034/xslF345X05/wk-form4_1740699768.xml ...

Halozyme Therapeutics Insider Sold Shares Worth $1,260,681, According to a Recent SEC Filing

Feb 28, 2025

03:50 AM EST, 02/28/2025 (MT Newswires) -- Michael J. LaBarre, Senior Vice President and Chief Technical Officer, on February 25, 2025, sold 21,697 shares in Halozyme Therapeutics ( HALO ) for $1,260,681. Following the Form 4 filing with the SEC, LaBarre has control over a total of 173,756 common shares of the company, with 173,756 shares held directly. SEC Filing:...

British Airways owner IAG profit beats estimates, plans share buyback

Feb 28, 2025

By Yadarisa Shabong and Joanna Plucinska Feb 28 (Reuters) - British Airways owner IAG reported a 27% jump in annual operating profit on Friday, beating market expectations as it curbed costs and growth in its lucrative transatlantic routes took off. European airlines overall have struggled in the past year with spiralling costs and delivery delays. IAG, which also owns Spanish...

Iovance Biotherapeutics Q4 Loss Narrows, Revenue Rises

Feb 28, 2025

03:50 AM EST, 02/28/2025 (MT Newswires) -- Iovance Biotherapeutics ( IOVA ) reported a Q4 net loss late Thursday of $0.26 per diluted share, narrower than a loss of $0.45 a year earlier. Analysts polled by FactSet expected a loss of $0.27. Revenue for the quarter ended Dec. 31 was $73.7 million, compared with $482,000 a year earlier. Analysts surveyed...